| |||||||||||||||||||||||||||
| |||||||||||||||||||||||||||
| |||||||||||||||||||||||||||
| |||||||||||||||||||||||||||
| |||||||||||||||||||||||||||
1 | AN ACT concerning regulation.
| ||||||||||||||||||||||||||
2 | Be it enacted by the People of the State of Illinois,
| ||||||||||||||||||||||||||
3 | represented in the General Assembly:
| ||||||||||||||||||||||||||
4 | Section 5. The Department of Public Health Powers and | ||||||||||||||||||||||||||
5 | Duties Law of the
Civil Administrative Code of Illinois is | ||||||||||||||||||||||||||
6 | amended by adding Section 2310-314 as follows: | ||||||||||||||||||||||||||
7 | (20 ILCS 2310/2310-314 new) | ||||||||||||||||||||||||||
8 | Sec. 2310-314. Sepsis screening protocols. | ||||||||||||||||||||||||||
9 | (a) The Department shall publish guidelines to assist | ||||||||||||||||||||||||||
10 | hospitals in developing the sepsis protocols required in | ||||||||||||||||||||||||||
11 | Section 6.23a of the Hospital Licensing Act. The guidelines | ||||||||||||||||||||||||||
12 | published by the Department shall include, but not be limited | ||||||||||||||||||||||||||
13 | to, an appropriate process for screening all patients to ensure | ||||||||||||||||||||||||||
14 | early recognition of patients with possible sepsis and, once | ||||||||||||||||||||||||||
15 | possible sepsis has been documented, establishing clear | ||||||||||||||||||||||||||
16 | timeframes for the administration of antibiotics and full | ||||||||||||||||||||||||||
17 | protocol implementation. | ||||||||||||||||||||||||||
18 | (b) The Department shall adopt rules to implement Section | ||||||||||||||||||||||||||
19 | 6.23a of the Hospital Licensing Act. | ||||||||||||||||||||||||||
20 | Section 10. The Hospital Licensing Act is amended by adding | ||||||||||||||||||||||||||
21 | Section 6.23a as follows: |
| |||||||
| |||||||
1 | (210 ILCS 85/6.23a new) | ||||||
2 | Sec. 6.23a. Sepsis screening protocols. | ||||||
3 | (a) As used in this Section: | ||||||
4 | "Sepsis" means a proven or suspected infection accompanied | ||||||
5 | by a systemic inflammatory response. | ||||||
6 | "Septic shock" means severe sepsis with persistent | ||||||
7 | hypotension or cardiovascular organ dysfunction despite | ||||||
8 | adequate intravenous fluid resuscitation. | ||||||
9 | "Severe sepsis" means sepsis plus at least one sign of | ||||||
10 | hypoperfusion or organ dysfunction. | ||||||
11 | (b) Each hospital shall adopt, implement, periodically | ||||||
12 | update, and submit to the Department evidence-based protocols | ||||||
13 | for the early recognition and treatment of patients with | ||||||
14 | sepsis, severe sepsis, or septic shock (sepsis protocols) that | ||||||
15 | are based on generally accepted standards of care. Sepsis | ||||||
16 | protocols must include components specific to the | ||||||
17 | identification, care, and treatment of adults and of children, | ||||||
18 | and must clearly identify where and when components will differ | ||||||
19 | for adults and for children. These protocols must also include | ||||||
20 | the following components: | ||||||
21 | (1) a process for the screening and early recognition | ||||||
22 | of patients with sepsis, severe sepsis, or septic shock; | ||||||
23 | (2) a process to identify and document individuals | ||||||
24 | appropriate for treatment through sepsis protocols, | ||||||
25 | including explicit criteria defining those patients who | ||||||
26 | should be excluded from the protocols, such as patients |
| |||||||
| |||||||
1 | with certain clinical conditions or who have elected | ||||||
2 | palliative care; | ||||||
3 | (3) guidelines for hemodynamic support with explicit | ||||||
4 | physiologic and biomarker treatment goals, methodology for | ||||||
5 | invasive or non-invasive hemodynamic monitoring, and | ||||||
6 | timeframe goals; | ||||||
7 | (4) for infants and children, guidelines for fluid | ||||||
8 | resuscitation with explicit timeframes for vascular access | ||||||
9 | and fluid delivery consistent with current, evidence-based | ||||||
10 | guidelines for severe sepsis and septic shock with defined | ||||||
11 | therapeutic goals for children; | ||||||
12 | (5) a procedure for identification of the infectious | ||||||
13 | source and delivery of early antibiotics with timeframe | ||||||
14 | goals; and | ||||||
15 | (6) criteria for use, where appropriate, of an invasive | ||||||
16 | protocol and for use of vasoactive agents. | ||||||
17 | (c) Each hospital shall ensure that professional staff with | ||||||
18 | direct patient care responsibilities and, as appropriate, | ||||||
19 | staff with indirect patient care responsibilities, including, | ||||||
20 | but not limited to, laboratory and pharmacy staff, are | ||||||
21 | periodically trained to implement the sepsis protocols | ||||||
22 | required under subsection (b). The hospital shall ensure | ||||||
23 | updated training of staff if the hospital initiates substantive | ||||||
24 | changes to the sepsis protocols. | ||||||
25 | (d) Each hospital shall submit the sepsis protocols | ||||||
26 | required under subsection (b) to the Department for review no |
| |||||||
| |||||||
1 | later than 6 months after the effective date of this amendatory | ||||||
2 | Act of the 99th General Assembly. A hospital must implement | ||||||
3 | these protocols no later than 45 days after receipt of a letter | ||||||
4 | from the Department indicating that the proposed protocols have | ||||||
5 | been reviewed and determined to be consistent with the criteria | ||||||
6 | established in this Section. A hospital must update protocols | ||||||
7 | based on newly emerging evidence-based standards. Protocols | ||||||
8 | shall be resubmitted at the request of the Department, but not | ||||||
9 | more frequently than once every 2 years unless the Department | ||||||
10 | identifies hospital-specific performance concerns. | ||||||
11 | (e) Each hospital shall be responsible for the collection, | ||||||
12 | use, and reporting of quality measures related to the | ||||||
13 | recognition and treatment of severe sepsis for purposes of | ||||||
14 | internal quality improvement and reporting to the Department. | ||||||
15 | These measures shall include, but not be limited to, data | ||||||
16 | sufficient to evaluate each hospital's adherence rate to its | ||||||
17 | own sepsis protocols, including adherence to timeframes and | ||||||
18 | implementation of all sepsis protocol components for adults and | ||||||
19 | children. | ||||||
20 | Each hospital shall submit data specified by the Department | ||||||
21 | to permit the Department to develop risk-adjusted sepsis | ||||||
22 | mortality rates in consultation with appropriate national, | ||||||
23 | hospital, and expert stakeholders. This data shall be reported | ||||||
24 | annually, or more frequently at the request of the Department, | ||||||
25 | and shall be subject to audit at the discretion of the | ||||||
26 | Department.
|